세계의 모공 각화증 치료 시장(2025-2033년)

The global Keratosis Pilaris Treatment market reached US$ 7.3 billion in 2024 and is expected to reach US$ 13.34 billion by 2033, growing at a CAGR of 6.1% during the forecast period 2025-2033.

Keratosis pilaris (KP) is a common, benign skin condition characterized by small, raised bumps caused by keratin buildup in hair follicles. It primarily affects the arms, thighs, and face. It can lead to cosmetic concerns, prompting treatment demand. The keratosis pilaris treatment market is expanding due to growing awareness and the increasing prevalence of the condition. Treatment options range from topical exfoliants like AHAs and retinoids to professional interventions such as laser therapies, with a rising interest in at-home devices and natural products.

Market Dynamics: Drivers & Restraints

Increasing prevalence of keratosis pilaris

The increasing prevalence of keratosis pilaris is expected to drive the keratosis pilaris treatment market. As keratosis pilaris becomes more widely recognized, there is a growing demand for effective solutions to address its cosmetic concerns. This higher incidence rate is expected to expand the availability of various treatment options, from over-the-counter creams to advanced dermatological procedures. It is a common condition occurring among the individuals. For instance, according to the National Institute of Health in 2023, it is stated that keratosis pilaris is a common dermatologic condition. The most common patient population is adolescents, with 50 to 80 percent affected. The disorder is also frequently seen in adults, with 40 percent of the adult population affected.

The rising number of people seeking ways to manage or reduce the appearance of KP further boosts market growth, creating a larger consumer base and fueling demand for both professional and at-home treatments.

Side effects associated with the treatment

Side effects associated with certain keratosis pilaris treatments, such as skin irritation, redness, and peeling from topical retinoids or laser therapies, are expected to hinder the market by restricting individuals from pursuing or continuing treatment. The potential for discomfort or adverse reactions may lead to decreased patient compliance, particularly for those with sensitive skin. This reluctance to use specific treatments, coupled with the need for ongoing management rather than a permanent cure, could slow the adoption of more aggressive or professional treatment options, limiting the overall growth of the keratosis pilaris treatment market.

Segment Analysis

The global keratosis pilaris treatment market is segmented based on type, treatment type, distribution channel, and region.

Treatment Type:

Topical Exfoliates is expected to dominate the global keratosis pilaris treatment market share

The topical exfoliates segment is expected to dominate the keratosis pilaris treatment market due to its accessibility, affordability, and effectiveness in managing the condition. Products containing alpha-hydroxy acids (AHAs), beta-hydroxy acids (BHAs), and urea are widely available over the counter and are often the first line of treatment for KP. These exfoliates help to remove dead skin cells and prevent keratin buildup, addressing the root cause of the condition.

As they are easy to use and offer a non-invasive solution, they appeal to a broad consumer base, driving significant demand in the market. This convenience and cost-effectiveness make topical exfoliants a preferred choice for individuals seeking to manage KP regularly.

Geographical Analysis

North America is expected to hold a significant position in the global keratosis pilaris treatment market share

North America is expected to dominate the keratosis pilaris treatment market due to a combination of factors, including a high prevalence of the condition, strong consumer awareness, and the presence of a large number of market players in the region. The region's focus on skincare and cosmetic treatments, coupled with a growing preference for non-invasive procedures, drives demand for both over-the-counter exfoliating products and professional treatments like laser therapy.

Additionally, North America has a well-established dermatology market, with easy access to specialized care and innovative treatment options, further fueling market growth. The rise of e-commerce and telemedicine also makes treatments more accessible, contributing to the region's leadership in the KP treatment market.

Competitive Landscape

The major global players in the keratosis pilaris treatment market include NEOSTRATA SA, SLMD Skincare, Advantice Health, LLC., BEIERSDORF, Touch Skin Care, G J PHARMACEUTICALS LLP, E-derma Pharma India Pvt. Ltd., VI Aesthetics, Bambang Pharmaceutical Depot Inc. and MooGoo among others.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Global Keratosis Pilaris Treatment Market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Dosage
• 3.2. Snippet by Application
• 3.3. Snippet by Distribution Channel
• 3.4. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Increasing prevalence of keratosis pilaris
  • 4.1.2. Restraints
    • 4.1.2.1. Side effects associated with the treatment
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Patent Analysis
• 5.5. Regulatory Analysis
• 5.6. SWOT Analysis
• 5.7. Unmet Needs

6. By Type

• 6.1. Introduction
  • 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Type
  • 6.1.2. Market Attractiveness Index, By Type
• 6.2. Over the Counter*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Prescription

7. By Treatment Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
  • 7.1.2. Market Attractiveness Index, By Treatment Type
• 7.2. Topical Exfoliates*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.2.3. Lotions
  • 7.2.4. Creams
  • 7.2.5. Others
• 7.3. Topical Retinoids
  • 7.3.1. Tretinoin
  • 7.3.2. Tazarotene
  • 7.3.3. Others
• 7.4. Laser Treatment
• 7.5. Others

8. By Distribution Channel

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 8.1.2. Market Attractiveness Index, By Distribution Channel
• 8.2. Hospitals Pharmacies*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Online Pharmacies
• 8.4. Retail Pharmacies

9. By Region

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 9.1.2. Market Attractiveness Index, By Region
• 9.2. North America
  • 9.2.1. Introduction
  • 9.2.2. Key Region-Specific Dynamics
    • 9.2.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.2.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
    • 9.2.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.2.3.1. U.S.
    • 9.2.3.2. Canada
    • 9.2.3.3. Mexico
• 9.3. Europe
  • 9.3.1. Introduction
  • 9.3.2. Key Region-Specific Dynamics
  • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
  • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.3.6.1. Germany
    • 9.3.6.2. U.K.
    • 9.3.6.3. France
    • 9.3.6.4. Spain
    • 9.3.6.5. Italy
    • 9.3.6.6. Rest of Europe
• 9.4. South America
  • 9.4.1. Introduction
  • 9.4.2. Key Region-Specific Dynamics
  • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
  • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.4.6.1. Brazil
    • 9.4.6.2. Argentina
    • 9.4.6.3. Rest of South America
• 9.5. Asia-Pacific
  • 9.5.1. Introduction
  • 9.5.2. Key Region-Specific Dynamics
  • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
  • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.5.6.1. China
    • 9.5.6.2. India
    • 9.5.6.3. Japan
    • 9.5.6.4. South Korea
    • 9.5.6.5. Rest of Asia-Pacific
• 9.6. Middle East and Africa
  • 9.6.1. Introduction
  • 9.6.2. Key Region-Specific Dynamics
  • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
  • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

10. Competitive Landscape

• 10.1. Competitive Scenario
• 10.2. Market Positioning/Share Analysis
• 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

Key Market Players

• 11.1. NEOSTRATA SA*
  • 11.1.1. Company Overview
  • 11.1.2. Product Portfolio
    • 11.1.2.1. Product Description
    • 11.1.2.2. Product Key Performance Indicators (KPIs)
    • 11.1.2.3. Historic and Forecasted Product Sales
    • 11.1.2.4. Product Sales Volume
  • 11.1.3. Financial Overview
    • 11.1.3.1. Company Revenue's
    • 11.1.3.2. Geographical Revenue Shares
    • 11.1.3.3. Revenue Forecasts
  • 11.1.4. Key Developments
    • 11.1.4.1. Mergers & Acquisitions
    • 11.1.4.2. Key Product Development Activities
    • 11.1.4.3. Regulatory Approvals etc.
  • 11.1.5. SWOT Analysis
• 11.2. SLMD Skincare
• 11.3. Advantice Health, LLC.
• 11.4. BEIERSDORF
• 11.5. Touch Skin Care
• 11.6. G J PHARMACEUTICALS LLP
• 11.7. E-derma Pharma India Pvt. Ltd.
• 11.8. VI Aesthetics
• 11.9. Bambang Pharmaceutical Depot Inc.
• 11.10. MooGoo
• Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

12. Appendix

• 12.1. About Us and Services
• 12.2. Contact Us